Use of sodium–glucose co‐transporter‐2 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of sodium–glucose co‐transporter‐2 inhibitors in patients with and without type 2 diabetes: implications for incident and prevalent heart failure

Published:2020-01-11 Issue:4 Volume:22 Page:604-617
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Butler Javed¹,Handelsman Yehuda²,Bakris George³,Verma Subodh⁴

Affiliation:

1. University of Mississippi Medical Center Jackson MS USA

2. Metabolic Institute of America Tarzana CA USA

3. Department of Medicine The University of Chicago Medicine Chicago IL USA

4. Division of Cardiac Surgery, St Michael's Hospital University of Toronto Toronto ON Canada

Funder

AstraZeneca

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1708

Reference108 articles.

1. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

2. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial

3. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

4. Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus

5. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Cardiovascular Outcomes: A Review of Literature;Cureus;2024-07-04

2. Safety and Efficacy of Dapagliflozin in Patients with Heart Failure with Reduced Ejection Fraction: Multicentre Retrospective Study on Echocardiographic Parameters and Biomarkers of Heart Congestion;Journal of Clinical Medicine;2024-06-16

3. Towards Optimal Cardiovascular Health: A Comprehensive Review of Preventive Strategies;Cureus;2024-05-22

4. Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression;Journal of Advanced Research;2024-05

5. The Effect of SGLT2 Inhibitor Therapy on Endothelial Progenitor Cell Function in Patients with Heart Failure;Journal of Cardiovascular Pharmacology;2024-04-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3